UBE2F and lung carcinoma: UBE2F knockout (KO) mildly affected the proliferation of lung cancer cells, but sharply promoted the inhibition of proliferation induced by cisplatin or carboplatin at a low dose, compared with wild-type (WT) since day 5 of giving drugs (Fig. 4B).